Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26824701)
Watch
English
Antiplatelet and anticoagulation therapy for acute coronary syndromes
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
title
Antiplatelet and anticoagulation therapy for acute coronary syndromes
(English)
1 reference
stated in
PubMed
main subject
anticoagulation
1 reference
based on heuristic
inferred from title
acute coronary syndrome
1 reference
based on heuristic
inferred from title
author
Jean-Sébastien Hulot
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
Deepak L. Bhatt
series ordinal
1
object named as
Deepak L Bhatt
1 reference
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
author name string
David J Moliterno
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
Robert A Harrington
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
6 June 2014
1 reference
stated in
PubMed
published in
Circulation Research
2 references
stated in
PubMed
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
volume
114
2 references
stated in
PubMed
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
issue
12
2 references
stated in
PubMed
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
page(s)
1929-1943
1 reference
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
cites work
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspirin dose for the prevention of cardiovascular disease: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antithrombotic strategies to reduce adverse clinical outcomes in patients with acute coronary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspirin resistance: more than just a laboratory curiosity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in plat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet inhibition with cangrelor during PCI
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensifying platelet inhibition--navigating between Scylla and Charybdis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bivalirudin for patients with acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prasugrel versus clopidogrel in patients with acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Facilitated PCI in patients with ST-elevation myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bivalirudin during primary PCI in acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early versus delayed, provisional eptifibatide in acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet inhibition with cangrelor in patients undergoing PCI.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous platelet blockade with cangrelor during PCI.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clopidogrel with or without omeprazole in coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apixaban with antiplatelet therapy after acute coronary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rivaroxaban in patients with a recent acute coronary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vorapaxar in the secondary prevention of atherothrombotic events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bivalirudin started during emergency transport for primary PCI.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Q22242895
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical aspects of platelet inhibitors and thrombus formation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathophysiology of coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiplatelet therapy and proton pump inhibition: clinician update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302737
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1161/CIRCRESAHA.114.302737
2 references
stated in
PubMed
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
Fatcat ID
release_yoeandmawzfz7csa6f3kjgdmaq
0 references
PubMed ID
24902976
2 references
stated in
PubMed
stated in
Europe PubMed Central
PubMed ID
24902976
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24902976%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
